Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2012, Article ID 684010, 5 pages
http://dx.doi.org/10.1155/2012/684010
Review Article

Regulation of Hepatic Paraoxonase-1 Expression

The Lipid Research Laboratory, The Ruth and Bruce Rappaport Faculty of Medicine, Technion—Israel Institute of Technology and Rambam Medical Center, 31096 Haifa, Israel

Received 24 December 2011; Accepted 29 January 2012

Academic Editor: Alejandro Gugliucci

Copyright © 2012 Bianca Fuhrman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Stocker and J. F. Keaney Jr., “New insights on oxidative stress in the artery wall,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1825–1834, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. Deakin, I. Leviev, M. Gomaraschi, L. Calabresi, G. Franceschini, and R. W. James, “Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism,” The Journal of Biological Chemistry, vol. 277, no. 6, pp. 4301–4308, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Aviram, M. Kaplan, M. Rosenblat, and B. Fuhrman, “Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development,” in Handbook of Experimental Pharmacology, vol. 170, pp. 263–300, 2005. View at Google Scholar · View at Scopus
  4. M. Aviram, M. Rosenblat, C. L. Bisgaier, R. S. Newton, S. L. Primo-Parmo, and B. N. La Du, “Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase,” Journal of Clinical Investigation, vol. 101, no. 8, pp. 1581–1590, 1998. View at Google Scholar · View at Scopus
  5. O. Rozenberg, D. M. Shih, and M. Aviram, “Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice,” Atherosclerosis, vol. 181, no. 1, pp. 9–18, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Aviram, M. Rosenblat, S. Billecke et al., “Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants,” Free Radical Biology and Medicine, vol. 26, no. 7-8, pp. 892–904, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Rozenberg, M. Rosenblat, R. Coleman, D. M. Shih, and M. Aviram, “Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice,” Free Radical Biology and Medicine, vol. 34, no. 6, pp. 774–784, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Mackness, R. Hunt, P. N. Durrington, and M. I. Mackness, “Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 7, pp. 1233–1238, 1997. View at Google Scholar · View at Scopus
  9. H. Tavori, M. Aviram, S. Khatib et al., “Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects,” Free Radical Biology and Medicine, vol. 46, no. 5, pp. 607–615, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. Y. Ikeda, M. Inoue, T. Suehiro, K. Arii, Y. Kumon, and K. Hashimoto, “Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes,” Acta Diabetologica, vol. 46, no. 3, pp. 239–242, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. M. Shih and A. J. Lusis, “The roles of PON1 and PON2 in cardiovascular disease and innate immunity,” Current Opinion in Lipidology, vol. 20, no. 4, pp. 288–292, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. M. Aviram, M. Rosenblat, S. Billecke et al., “Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants,” Free Radical Biology and Medicine, vol. 26, no. 7-8, pp. 892–904, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. van der Gaag, A. van Tol, L. M. Scheek et al., “Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men,” Atherosclerosis, vol. 147, no. 2, pp. 405–410, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. G. P. Jarvik, N. T. Tsai, L. A. McKinstry et al., “Vitamin C and E intake is associated with increased paraoxonase activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 8, pp. 1329–1333, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Fuhrman and M. Aviram, “Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation,” Annals of the New York Academy of Sciences, vol. 957, pp. 321–324, 2002. View at Google Scholar · View at Scopus
  16. M. Aviram, L. Dornfeld, M. Rosenblat et al., “Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1062–1076, 2000. View at Google Scholar · View at Scopus
  17. S. L. Primo-Parmo, R. C. Sorenson, J. Teiber, and B. N. La Du, “The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family,” Genomics, vol. 33, no. 3, pp. 498–507, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Deakin, S. Guernier, and R. W. James, “Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin,” Pharmacogenetics and Genomics, vol. 17, no. 6, pp. 451–457, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. K. R. Feingold, R. A. Memon, A. H. Moser, and C. Grunfeld, “Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response,” Atherosclerosis, vol. 139, no. 2, pp. 307–315, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. A. B. Ali, Q. Zhang, Y. K. Lim, D. Fang, L. Retnam, and S. K. Lim, “Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation,” Free Radical Biology and Medicine, vol. 34, no. 7, pp. 824–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. B. J. Van Lenten, A. C. Wagner, M. Navab, and A. M. Fogelman, “Oxidized phospholipids induce changes in hepatic paraoxonase and apoJ but not monocyte chemoattractant protein-1 via interleukin-6,” The Journal of Biological Chemistry, vol. 276, no. 3, pp. 1923–1929, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. J. Marsillach, J. Camps, N. Ferré et al., “Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease,” BMC Gastroenterology, vol. 9, article 3, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. Camps, J. Marsillach, A. Rull, C. Alonso-Villaverde, and J. Joven, “Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation,” Advances in Experimental Medicine and Biology, vol. 660, pp. 5–18, 2010. View at Publisher · View at Google Scholar
  24. C. Y. Han, T. Chiba, J. S. Campbell et al., “Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 8, pp. 1806–1813, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Stocker and J. F. Keaney Jr., “New insights on oxidative stress in the artery wall,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1825–1834, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. D. Nguyen, N. D. Hung, P. Cheon-Ho, K. M. Ree, and S. Dai-Eun, “Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1),” Biochimica et Biophysica Acta - General Subjects, vol. 1790, no. 3, pp. 155–160, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. N. Franco-Pons, J. Marsillach, J. Joven, J. Camps, and D. Closa, “Serum paraoxonase undergoes inhibition and proteolysis during experimental acute pancreatitis,” Journal of Gastrointestinal Surgery, vol. 12, no. 5, pp. 891–899, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. X. Moren, S. Deakin, M. L. Liu, M. R. Taskinen, and R. W. James, “HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress,” Journal of Lipid Research, vol. 49, no. 6, pp. 1246–1253, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. O. Rozenberg and M. Aviram, “S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity,” Biochemical and Biophysical Research Communications, vol. 351, no. 2, pp. 492–498, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Deakin, X. Moren, and R. W. James, “HDL oxidation compromises its influence on paraoxonase-1 secretion and its capacity to modulate enzyme activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 1146–1152, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. S. D. Nguyen and D. E. Sok, “Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action,” Free Radical Research, vol. 37, no. 12, pp. 1319–1330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Tavori, M. Aviram, S. Khatib et al., “Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284,” Free Radical Biology and Medicine, vol. 50, no. 1, pp. 148–156, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. Trudel, D. Sinnett, R. W. James et al., “Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats,” Journal of Cellular Biochemistry, vol. 96, no. 2, pp. 404–411, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. S. C. Hong, S. P. Zhao, and Z. H. Wu, “Probucol up-regulates paraoxonase 1 expression in hepatocytes of hypercholesterolemic rabbits,” Journal of Cardiovascular Pharmacology, vol. 47, no. 1, pp. 77–81, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Gouédard, N. Koum-Besson, R. Barouki, and Y. Morel, “Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins,” Molecular Pharmacology, vol. 63, no. 4, pp. 945–956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Deakin, I. Leviev, S. Guernier, and R. W. James, “Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 11, pp. 2083–2089, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. F. Osaki, Y. Ikeda, T. Suehiro et al., “Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells,” Atherosclerosis, vol. 176, no. 2, pp. 279–287, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. K. Ota, T. Suehiro, K. Arii et al., “Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene,” Metabolism, vol. 54, no. 2, pp. 142–150, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. K. Arii, T. Suehiro, K. Ota et al., “Pitavastatin induces PON1 expression through p44/42 mitogen-activated protein kinase signaling cascade in Huh7 cells,” Atherosclerosis, vol. 202, no. 2, pp. 439–445, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. K. Arii, T. Suehiro, Y. Ikeda et al., “Role of protein kinase C in pitavastatin-induced human paraoxonase i expression in Huh7 cells,” Metabolism, vol. 59, no. 9, pp. 1287–1293, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. Gutierrez, E. P. Ratliff, A. M. Andres, X. Huang, W. L. McKeehan, and R. A. Davis, “Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 301–306, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. Y. Ikeda, T. Suehiro, K. Arii, Y. Kumon, and K. Hashimoto, “High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes,” Metabolism, vol. 57, no. 12, pp. 1725–1732, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. B. Fuhrman and M. Aviram, “Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation,” Annals of the New York Academy of Sciences, vol. 957, pp. 321–324, 2002. View at Google Scholar · View at Scopus
  44. M. Aviram, L. Dornfeld, M. Rosenblat et al., “Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice,” American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1062–1076, 2000. View at Google Scholar · View at Scopus
  45. C. Schrader and G. Rimbach, “Determinants of paraoxonase 1 status: genes, drugs and nutrition,” Current Medicinal Chemistry, vol. 18, no. 36, pp. 5624–5643, 2011. View at Google Scholar
  46. L. G. Costa, G. Giordano, and C. E. Furlong, “Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on,” Biochemical Pharmacology, vol. 81, no. 3, pp. 337–344, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. Aviram and M. Rosenblat, “Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences,” Current Opinion in Lipidology, vol. 16, no. 4, pp. 393–399, 2005. View at Google Scholar · View at Scopus
  48. M. Gong, M. Garige, R. Varatharajalu et al., “Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation,” Biochemical and Biophysical Research Communications, vol. 379, no. 4, pp. 1001–1004, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. C. Gouédard, R. Barouki, and Y. Morel, “Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism,” Molecular and Cellular Biology, vol. 24, no. 12, pp. 5209–5222, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. C. Gouédard, R. Barouki, and Y. Morel, “Induction of the paraoxonase-1 gene expression by resveratrol,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 12, pp. 2378–2383, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  51. C. C. Cheng, C. M. Hsueh, K. W. Liang, C. T. Ting, C. L. Wen, and S. L. Hsu, “Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase 1 gene transcription by berberine in human HepG2 cells,” European Journal of Pharmacology, vol. 650, pp. 519–525, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. M. Aviram, L. Dornfeld, M. Kaplan et al., “Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans,” Drugs under Experimental and Clinical Research, vol. 28, no. 2-3, pp. 49–62, 2002. View at Google Scholar · View at Scopus
  53. J. Khateeb, A. Gantman, A. J. Kreitenberg, M. Aviram, and B. Fuhrman, “Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-γ pathway,” Atherosclerosis, vol. 208, no. 1, pp. 119–125, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. Gugliucci, “Beyond the antioxidant properties: pomegranate juice polyphenols increase hepatocyte paraoxonase 1 secretion,” Atherosclerosis, vol. 208, no. 1, pp. 28–29, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. B. Fuhrman, O. Nitzan, R. Karry, N. Volkova, I. Dumler, and M. Aviram, “Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner,” Atherosclerosis, vol. 195, no. 2, pp. e108–e116, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  56. B. Fuhrman, J. Khateeb, M. Shiner et al., “Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1361–1367, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. J. Khateeb, Y. Kiyan, M. Aviram, S. Tkachuk, I. Dumler, and B. Fuhrman, “Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-γ nuclear export,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 449–458, 2012. View at Publisher · View at Google Scholar · View at PubMed